The Spinal Muscular Atrophy (SMA) Foundation, a non-profit, organization whose mission is to accelerate the development of treatments for SMA, the leading cause of genetic death in young children, visited the Nasdaq MarketSite in Times Square on August 17, 2018. In honor of the occasion, Dinakar Singh, Co-Founder and Chairman of the Board of Directors, rang the Opening Bell. The Spinal Muscular Atrophy Foundation was joined by several of its collaborators including representatives from academia, the clinical community, and industry. August is recognized as Spinal Muscular Atrophy Awareness month.
Photography courtesy of Nasdaq, Inc.